Paper42953262PubMed
Artificial Intelligence-Assisted Systematic Literature Reviews in Metabolic Phenotyping: A Methodological Framework and Validation Study.
Cox M and 8 others. Phenomics, 2026.
Cite this record
ConductScience Library. Artificial Intelligence-Assisted Systematic Literature Reviews in Metabolic Phenotyping: A Methodological Framework and Validation Study. Papers, record 42953262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42953262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artificial Intelligence-Assisted Systematic Literature Reviews in Metabolic Phenotyping: A Methodological Framework and Validation Study.
- Journal
- Phenomics
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26979502 | Metabolomics: beyond biomarkers and towards mechanisms. | Nat Rev Mol Cell Biol | 2016 | https://conductscience.org/library/papers/26979502 | PubMed |
| 2 | 37284994 | Prompt Engineering with ChatGPT: A Guide for Academic Writers. | Ann Biomed Eng | 2023 | https://conductscience.org/library/papers/37284994 | PubMed |
| 3 | 41626932 | Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2. | Res Synth Methods | 2025 | https://conductscience.org/library/papers/41626932 | PubMed |
| 4 | 36501014 | Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. | Nutrients | 2022 | https://conductscience.org/library/papers/36501014 | PubMed |
| 5 | 33213530 | Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. | Trials | 2020 | https://conductscience.org/library/papers/33213530 | PubMed |
| 6 | 28242767 | Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry. | BMJ Open | 2017 | https://conductscience.org/library/papers/28242767 | PubMed |
| 7 | 38614374 | SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38614374 | PubMed |
| 8 | 36292286 | Herbal Medicines for Post-Acute Sequelae (Fatigue or Cognitive Dysfunction) of SARS-CoV-2 Infection: A Phase 2 Pilot Clinical Study Protocol. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/36292286 | PubMed |
| 9 | 38219861 | Metabolomics and Risk of Dementia: A Systematic Review of Prospective Studies. | J Nutr | 2024 | https://conductscience.org/library/papers/38219861 | PubMed |
| 10 | 38029644 | Association Between Human Metabolomics and Rheumatoid Arthritis: A Systematic Review and Meta-analysis. | Arch Med Res | 2024 | https://conductscience.org/library/papers/38029644 | PubMed |
| 11 | 37516715 | Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects. | Amino Acids | 2023 | https://conductscience.org/library/papers/37516715 | PubMed |
| 12 | 29844477 | Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study. | Sci Rep | 2018 | https://conductscience.org/library/papers/29844477 | PubMed |
| 13 | 38513133 | Stratification of Sepsis Patients on Admission into the Intensive Care Unit According to Differential Plasma Metabolic Phenotypes. | J Proteome Res | 2024 | https://conductscience.org/library/papers/38513133 | PubMed |
| 14 | 34193506 | Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil. | BMJ Open | 2021 | https://conductscience.org/library/papers/34193506 | PubMed |
| 15 | 36879536 | Using ChatGPT to conduct a literature review. | Account Res | 2024 | https://conductscience.org/library/papers/36879536 | PubMed |
| 16 | 35909178 | Hierarchy of Evidence Within the Medical Literature. | Hosp Pediatr | 2022 | https://conductscience.org/library/papers/35909178 | PubMed |
| 17 | 38548274 | Lung MRI identifies potentially treatable subtypes of long COVID. | Eur Respir J | 2024 | https://conductscience.org/library/papers/38548274 | PubMed |
| 18 | 24039616 | Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). | Metabolomics | 2007 | https://conductscience.org/library/papers/24039616 | PubMed |
| 19 | 37511373 | Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511373 | PubMed |
| 20 | 41626912 | Generative artificial intelligence use in evidence synthesis: A systematic review. | Res Synth Methods | 2025 | https://conductscience.org/library/papers/41626912 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42953262
GET https://conductscience.org/api/papers/v1/42953262/references?page=2